Unlock stock picks and a broker-level newsfeed that powers Wall Street.
12.20
-0.53
(-4.20%)
At close: April 1 at 4:00:00 PM EDT
12.99
+0.78
+(6.43%)
Pre-Market: 4:20:20 AM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 12 | 12 | 12 | 11 |
| Avg. Estimate | -0.46 | -0.94 | -3.32 | -3.83 |
| Low Estimate | -1.37 | -1.35 | -5.52 | -5.42 |
| High Estimate | 2.69 | -0.14 | 1.53 | -0.92 |
| Year Ago EPS | -1.02 | -1.38 | -5 | -3.32 |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 11 | 11 | 15 | 14 |
| Avg. Estimate | 116.27M | 51.27M | 320.74M | 225.46M |
| Low Estimate | -- | -- | 2.5M | 38.75M |
| High Estimate | 534.7M | 150.75M | 906.5M | 565.7M |
| Year Ago Sales | -- | -- | 3.55M | 320.74M |
| Sales Growth (year/est) | 0.00% | 0.00% | 8,932.46% | -29.71% |
Earnings History
| Currency in USD | 3/31/2024 | 6/30/2024 | 9/30/2024 | 12/31/2024 |
|---|---|---|---|---|
| EPS Est. | -0.2 | -0.59 | -0.92 | -0.72 |
| EPS Actual | -1.02 | -1.38 | -1.37 | -1.39 |
| Difference | -0.82 | -0.79 | -0.45 | -0.67 |
| Surprise % | -422.76% | -134.53% | -48.60% | -92.16% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -0.46 | -0.94 | -3.32 | -3.83 |
| 7 Days Ago | -0.47 | -1.02 | -3.55 | -3.94 |
| 30 Days Ago | -0.47 | -1.02 | -3.6 | -3.94 |
| 60 Days Ago | -0.7 | -0.9 | -3.37 | -3.98 |
| 90 Days Ago | -0.69 | -0.89 | -3.36 | -3.88 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | 5 | 3 | 1 | 1 |
| Up Last 30 Days | 1 | 1 | 1 | 1 |
| Down Last 7 Days | 4 | 5 | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| ARWR | 54.69% | 32.11% | 33.65% | -15.41% |
| S&P 500 | 6.69% | 6.80% | 9.98% | 14.34% |
Upgrades & Downgrades
| Reiterates | B. Riley Securities: Buy to Buy | 2/14/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 2/12/2025 |
| Reiterates | RBC Capital: Outperform to Outperform | 2/11/2025 |
| Maintains | Chardan Capital: Buy to Buy | 2/11/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 1/23/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 1/22/2025 |
Related Tickers
ALNY Alnylam Pharmaceuticals, Inc.
255.76
-5.28%
WVE Wave Life Sciences Ltd.
7.74
-4.21%
PRQR ProQR Therapeutics N.V.
1.2900
-3.01%
IONS Ionis Pharmaceuticals, Inc.
27.26
-9.65%
SRPT Sarepta Therapeutics, Inc.
61.91
-2.99%
BEAM Beam Therapeutics Inc.
17.64
-9.70%
RCKT Rocket Pharmaceuticals, Inc.
5.81
-12.89%
SGMO Sangamo Therapeutics, Inc.
0.5701
-13.07%
CYTK Cytokinetics, Incorporated
37.50
-6.69%
ABUS Arbutus Biopharma Corporation
3.4800
-0.29%